Obstructive Sleep Apnea Syndrome and Metabolic Diseases

Endocrinology. 2018 Jul 1;159(7):2670-2675. doi: 10.1210/en.2018-00248.

Abstract

With the rapid changes in lifestyle in modern society, including the high nutritional intake and reduced physical activity, the incidence of metabolic diseases has been increasing year by year. Obstructive sleep apnea syndrome (OSAS) is a sleep disorder, usually characterized by sudden pauses of breathing during sleep and an interrupted sleep rhythm. Although the pathological mechanism remains poorly understood, it has been strongly associated with metabolic diseases, including obesity, insulin resistance, type 2 diabetes mellitus (T2DM), and nonalcoholic fatty liver disease (NAFLD). In the present mini-review, we briefly summarize the connections between OSAS, obesity, T2DM, and NAFLD, which might help us to better understand the pathogenesis of human diseases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology
  • Humans
  • Insulin Resistance / physiology
  • Metabolic Diseases / complications*
  • Metabolic Diseases / metabolism*
  • Metabolic Diseases / pathology
  • Non-alcoholic Fatty Liver Disease / complications
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology
  • Obesity / complications
  • Obesity / metabolism
  • Obesity / pathology
  • Sleep Apnea, Obstructive / complications*
  • Sleep Apnea, Obstructive / metabolism*
  • Sleep Apnea, Obstructive / pathology